Fixed income investors know that bond prices and yields move inverse of one another. That means when yields decline, prices rise.

Target (TGT) operates in a challenging gray area, lacking clear advantages over Walmart, Costco, or premium retailers. Despite recent struggles and market skepticism, TGT's long-term revenue growth, digital initiatives, and membership potential provide credible turnaround triggers. The new CEO's focus on merchandising, guest experience, and technology, alongside private label expansion and macro recovery, could drive margin and sales improvements.

Nasdaq 100 rallies as Oracle, Broadcom lead tech gains. Traders eye key resistance and upcoming earnings for US stock market direction.

Altria Group's latest payout raise met my expectations, extending its dividend growth streak to 56 straight years. The tobacco giant's deal with KT&G is a low-risk way to cash in on growth in international markets. Altria Group's debt-to-EBITDA ratio remains at its target of 2x.

Amazon.com Inc (NASDAQ:AMZN) heads into its third-quarter earnings later this month with momentum on multiple fronts. Citi expects the focus to remain on Amazon Web Services (AWS) and the pace of its ongoing capacity buildout, even as the retail business continues to gain market share across categories from electronics to groceries.

NEW YORK--(BUSINESS WIRE)---- $CHTR #CHTR--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Charter Communications, Inc. (“Charter” or the “Company”) (NASDAQ: CHTR) and reminds investors of the October 13, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgi.

NEW YORK--(BUSINESS WIRE)---- $UNCY #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY) and reminds investors of the October 14, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Geor.

Zeta Holdings remains a "Buy," with intrinsic value near $30 despite recent volatility from U.S.-China trade tensions impacting AI stocks. ZETA delivered strong Q2 results, raising guidance and demonstrating robust free cash flow, with management targeting 20% annual revenue growth through 2028. Technical analysis suggests a favorable risk/reward for buying ZETA between $16 and $17, ahead of the upcoming Q3 earnings report.

WTI tumbled 4% as speculative shorts strengthened and the oil-gold ratio hit pandemic lows, signaling more downside ahead of the IEA report.

I see a clear path for Hims & Hers Health to reach $100 a share, and I plan to be there when it gets there. HIMS expects revenue growth to rebound, driven by weight loss and new health offerings, aiming for 30%+ growth in 2026. Despite a temporary dip into negative free cash flow, HIMS maintains strong profitability targets and trades at an attractive 24x forward free cash flow.

NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of WPP plc (“WPP” or the “Company”) (NYSE: WPP) between February 27, 2025 and July 8, 2025, inclusive. For more information, submit a form at WPP plc Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at [email protected], or call us at (212) 951-2030.

NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Snap Inc. (“Snap” or the “Company”) (NYSE: SNAP) between April 29 , 202 5 and August 5 , 202 5, inclusive. Should You Join This Class Action Lawsuit?

NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Dow Inc. (“Dow” or the “Company”) (NYSE: DOW) between January 30 , 202 5 and July 23 , 202 5, inclusive. Should You Join This Class Action Lawsuit?

NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Fluor Corporation (“Fluor” or the “Company”) (NYSE: FLR) between February 18 , 202 5 and July 31 , 202 5, inclusive. Should You Join This Class Action Lawsuit?

NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Tronox Holdings PLC (“Tronox” or the “Company”) (NYSE: TROX) between February 12 , 202 5 and July 30 , 202 5, inclusive. Should You Join This Class Action Lawsuit?

NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) between August 8 , 202 4 and August 14 , 202 5, inclusive. Should You Join This Class Action Lawsuit?

NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of V.F. Corporation (“VFC” or the “Company”) (NYSE: VFC) between October 30 , 202 3 and May 20 , 202 5, inclusive.

NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of C3.ai, Inc. (“C3” or the “Company”) (NYSE: AI) between February 26 , 202 5 and August 8 , 202 5, inclusive. Should You Join This Class Action Lawsuit?

NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) between May 7 , 202 5 and August 5 , 202 5, inclusive. Should You Join This Class Action Lawsuit?

Salesforce, Inc.'s stock shows technical strength, hinting at an upside reversal towards $340-$360, supported by its relative resilience during recent market downturns. CRM's Q2 FY2026 results exceeded expectations, with strong revenue and EPS growth, alongside expanding EBIT margins and robust operating cash flow projections for FY2026. The company's AI and Data Cloud product line is rapidly accelerating, growing 120% YoY and securing 6,000+ Agentforce deals, indicating strong commercialization momentum.